(Total Views: 536)
Posted On: 05/29/2018 6:42:00 PM
Post# of 27
NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) Enters Exclusive Licensing Agreement for RIPPLE SC Technology
Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) this morning announced its entry into an exclusive agreement with Stillwater Brands to license RIPPLE SC (Soluble Cannabinoids) ingredient technology and other proprietary beverage and food technologies and formulations related to cannabinoid-infused consumer packaged goods, including micro-dose and full-dose tea sticks, within Canada and certain international jurisdictions outside of the United States. “We are excited to have the opportunity to provide a platform to introduce Stillwater’s advanced technologies and formulations worldwide using TGOD’s premium organic ingredients,” Rob Anderson, co-chairman and CEO of TGOD, stated in the news release. “This technology will allow TGOD to provide patients and customers around the globe with novel and effective dose-controlled delivery systems that are safer, more standardized, and more discreet than most current cannabinoid delivery systems.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
Cannabis-focused research and development company The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) this morning announced its entry into an exclusive agreement with Stillwater Brands to license RIPPLE SC (Soluble Cannabinoids) ingredient technology and other proprietary beverage and food technologies and formulations related to cannabinoid-infused consumer packaged goods, including micro-dose and full-dose tea sticks, within Canada and certain international jurisdictions outside of the United States. “We are excited to have the opportunity to provide a platform to introduce Stillwater’s advanced technologies and formulations worldwide using TGOD’s premium organic ingredients,” Rob Anderson, co-chairman and CEO of TGOD, stated in the news release. “This technology will allow TGOD to provide patients and customers around the globe with novel and effective dose-controlled delivery systems that are safer, more standardized, and more discreet than most current cannabinoid delivery systems.”
Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
(0)
(0)
